Blue Zone Wealth Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Blue Zone Wealth Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-41,000	Closed	-$29.4K	–	94
2024 Q1	$29.4K	Hold	41,000	–	–	0.01%	85
2023 Q4	$34.9K	Buy	41,000 +10,000	+32%	+$9.66K	0.01%	79
2023 Q3	$42.5K	Buy	31,000 +1,000	+3%	+$2.17K	0.02%	78
2023 Q2	$75.6K	Buy	30,000 +2,500	+9%	+$5.3K	0.03%	75
2023 Q1	$62.4K	Buy	+27,500	New	+$69.7K	0.03%	78

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Blue Zone Wealth Advisors's VAXX Position: Q2 2024 in Review

Blue Zone Wealth Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 41,000 shares — an estimated $29.4K sold.

Blue Zone Wealth Advisors first reported a position in VAXX in Q1 2023 and held it in 5 quarters. The position peaked at $75.6K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Blue Zone Wealth Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Blue Zone Wealth Advisors sold 41,000 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $29.4K.
Blue Zone Wealth Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 5 quarters.
Blue Zone Wealth Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $75.6K in Q2 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Blue Zone Wealth Advisors's 13F filing for Q2 2024, filed 12 Jul 2024.